Qoustic Wound Therapy System™ - FDA-cleared advanced ultrasound technology for biofilm removal and accelerated wound healing
The Arobella Qoustic Wound Therapy System combines innovative low-frequency ultrasound technology with irrigation and standard curettage to provide non-invasive, highly effective wound debridement and biofilm removal.
Trusted by leading medical institutions including Mayo Clinic, Walter Reed Military Medical Center, Johns Hopkins Bayview Medical Center, Duke Medicine, and Baylor University Medical Center.
Low-frequency 35 kHz ultrasound disrupts and removes resistant biofilms including MRSA
Selective removal of necrotic tissue without damaging healthy tissue
FDA-cleared (K131096) and used by Mayo Clinic, Walter Reed, Johns Hopkins
Patients report 50-70% pain reduction after initial treatments
Long-standing wounds resistant to conventional treatment
Diabetic foot and leg ulcers with biofilm colonization
Thermal injuries requiring specialized debridement
Post-operative wounds with delayed healing
Stage III-IV pressure injuries
Wounds with MRSA and resistant biofilms
Real-world outcomes from clinical practice
Patient with 6-month non-healing diabetic foot ulcer
8 sessions of Arobella QWTS over 4 weeks
Complete wound closure with 95% reduction in wound area
Post-surgical wound with MRSA biofilm colonization
6 sessions targeting biofilm disruption
Biofilm eradication and successful epithelialization
Second-degree burn with delayed healing
10 sessions combined with standard care
Accelerated healing, reduced pain, improved cosmetic outcome
Contact our clinical team to discuss how Arobella QWTS can enhance your wound care program